A decade of studies concluded that liver expression in CF patients is influenced by modifier genes like mannose-binding lectin and AAT [18], but such genes modulate the risk for liver disease only in a small percentage of CF patients. This evidence concerns the gene MBL2 and cystic fibrosis.